Description
REVLIMID is a prescription medicine, used to treat adults with multiple myeloma (MM) in combination with the medicine dexamethasone, or as maintenance treatment after autologous hematopoietic stem cell transplantation (a type of stem cell transplant that uses your own stem cells).
- REVLIMID should not be used to treat people who have chronic lymphocytic leukemia (CLL) unless they are participants in a controlled clinical trial.
- It is not known if REVLIMID is safe and effective in children.
How to use:
- Take REVLIMID exactly as prescribed
- Swallow REVLIMID capsules whole, with water, 1 time a day. Do not open, break, or chew your capsules.
- REVLIMID may be taken with or without food.
- Take REVLIMID at about the same time each day.
Caution & Warnings:
- Do not take REVLIMID if you:
- are pregnant, plan to become pregnant, or become pregnant during treatment with REVLIMID.
- are allergic to lenalidomide or any of the ingredients in REVLIMID.
Side Effects:
- Possible birth defects
- Increased risk of death in people who have chronic lymphocytic leukemia (CLL).
- Risk of new cancers (malignancies).
- Severe liver problems, including liver failure and death.
Ingredients:
- lenalidomide 15Mg.
Reviews
There are no reviews yet.